Cargando…

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients

Ovarian cancer is one of the most common gynecologic malignancies. It is characterized by a high mortality rate, which is mainly due to the asymptomatic course of the disease. In light of the high mortality rate and increasing morbidity, new diagnostic methods are being explored to enable earlier de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kicman, Aleksandra, Niczyporuk, Marek, Kulesza, Monika, Motyka, Joanna, Ławicki, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719685/ https://www.ncbi.nlm.nih.gov/pubmed/36474934 http://dx.doi.org/10.2147/CMAR.S385658

Ejemplares similares

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)

Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2022)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Influence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase-12 in psoriatic patients
por: Głażewska, Edyta K., et al.
Publicado: (2017)

Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis
por: Zajkowska, Monika, et al.
Publicado: (2018)

Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls
por: Kobus, Agnieszka, et al.
Publicado: (2019)

Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer
por: Będkowska, Grażyna E., et al.
Publicado: (2021)

Matrilysins and Stromelysins in Pathogenesis and Diagnostics of Cancers
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2016)

Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2021)

Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors
por: El-Chaer, William Khalil, et al.
Publicado: (2018)

Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2017)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis
por: Chen, Chen, et al.
Publicado: (2020)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
por: Fu, Ziyi, et al.
Publicado: (2015)

Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment
por: Gonzalez-Avila, Georgina, et al.
Publicado: (2022)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
por: Zhang, Y., et al.
Publicado: (2017)

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
por: Kicman, Aleksandra, et al.
Publicado: (2020)

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis
por: Lubowicka, Emilia, et al.
Publicado: (2019)

Role of serum matrix metalloproteinase in the diagnosis of gastric cancer
por: Liu, Jian, et al.
Publicado: (2020)

Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer
por: Rasool, Mahmood, et al.
Publicado: (2016)

Expression of Matrix Metalloproteinase-7 Predicts Poor Prognosis in Gastric Cancer
por: Wattanawongdon, Wareeporn, et al.
Publicado: (2022)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2017)

Stage-Dependent Levels of Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase 9 in the Prognosis of Colorectal Cancer
por: Večurkovská, Ivana, et al.
Publicado: (2023)

Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome
por: Wang, Shujie, et al.
Publicado: (2019)

Genomic analysis of matrix metalloproteinases affecting the prognosis and immunogenic profile of gastric cancer
por: Yuan, Chaofeng, et al.
Publicado: (2023)

Metalloproteinases in Ovarian Cancer
por: Carey, Preston, et al.
Publicado: (2021)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2019)

Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers
por: Kolano, Paweł, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9okb4knnsq09bk7dgut6917bc3